Artelo Biosciences, Inc.
ARTL
$5.98
-$0.21-3.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.98% | 1.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.84% | -3.48% | |||
| Operating Income | 6.84% | 3.48% | |||
| Income Before Tax | 17.95% | 29.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.95% | 29.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.95% | 29.00% | |||
| EBIT | 6.84% | 3.48% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 77.64% | 35.24% | |||
| Normalized Basic EPS | 77.26% | 10.96% | |||
| EPS Diluted | 77.64% | 35.24% | |||
| Normalized Diluted EPS | 77.26% | 10.96% | |||
| Average Basic Shares Outstanding | 266.98% | 9.64% | |||
| Average Diluted Shares Outstanding | 266.98% | 9.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||